{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:23:54Z","timestamp":1793845434638,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011119","name":"University of Georgia College of Veterinary Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011119","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015515","name":"The University of Iowa Roy J and Lucille A Carver College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.102975","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:05:01Z","timestamp":1780934701000},"page":"102975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["CFTR gene delivery to human airway epithelia using parainfluenza virus 5 amplifying virus-like particles"],"prefix":"10.1016","volume":"37","author":[{"given":"Mark A.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7189-2323","authenticated-orcid":false,"given":"Katarina","family":"Kulhankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9785-6023","authenticated-orcid":false,"given":"Mar\u00eda Cristina","family":"Gingerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Marquez","family":"Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Thornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4067-577X","authenticated-orcid":false,"suffix":"Jr.","given":"Paul B.","family":"McCray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102975_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102975_bib2","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1807119","article-title":"VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Davies","year":"2018","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.omtn.2026.102975_bib3","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.omtn.2026.102975_bib4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.omtn.2026.102975_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.aaw0553","article-title":"Making precision medicine personal for cystic fibrosis","volume":"365","author":"Manfredi","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102975_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101244","article-title":"Durable transgene expression and efficient re-administration after rAAV2.5T-mediated fCFTRDeltaR gene delivery to adult ferret lungs","volume":"32","author":"Tang","year":"2024","journal-title":"Molecular therapy Methods & clinical development"},{"key":"10.1016\/j.omtn.2026.102975_bib7","doi-asserted-by":"crossref","first-page":"2301683","DOI":"10.1183\/13993003.01683-2023","article-title":"Pharmacological and pre-clinical safety profile of rSIV.F\/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy","volume":"65","author":"Moiseenko","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.omtn.2026.102975_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1089\/hum.2007.022","article-title":"Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial","volume":"18","author":"Moss","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102975_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ng0994-42","article-title":"Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis","volume":"8","author":"Crystal","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2026.102975_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0092-8674(93)80063-K","article-title":"Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis","volume":"75","author":"Zabner","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.102975_bib11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM199509283331302","article-title":"A controlled study of adenoviral-vector-mediated gene transfer in the nasal eptihelium of patients with cystic fibrosis","volume":"333","author":"Knowles","year":"1995","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.omtn.2026.102975_bib12","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1089\/10430349950016384","article-title":"A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis","volume":"10","author":"Zuckerman","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102975_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.125.2.509","article-title":"Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial","volume":"125","author":"Moss","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.omtn.2026.102975_bib14","article-title":"A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates","volume":"99","author":"Beavis","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102975_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj7611","article-title":"Intranasal parainfluenza virus type 5 (PIV5)-vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study","volume":"9","author":"Spearman","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.102975_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.623996","article-title":"Parainfluenza Virus 5 Priming Followed by SIV\/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates","volume":"12","author":"Xiao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2026.102975_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41541-017-0031-7","article-title":"Developing a platform system for gene delivery: amplifying virus-like particles (AVLP) as an influenza vaccine","volume":"2","author":"Wei","year":"2017","journal-title":"npj Vaccines"},{"key":"10.1016\/j.omtn.2026.102975_bib18","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1016\/j.vaccine.2019.04.042","article-title":"Parainfluenza virus 5 (PIV5) amplifying virus-like particles expressing respiratory syncytial virus (RSV) antigens protect mice against RSV infection","volume":"37","author":"Huertas-D\u00edaz","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2026.102975_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.omtm.2021.02.020","article-title":"Increased CFTR expression and function from an optimized lentiviral vector for cystic fibrosis gene therapy","volume":"21","author":"Marquez Loza","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.102975_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1476331","article-title":"Current landscape of cystic fibrosis gene therapy","volume":"15","author":"Plasschaert","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtn.2026.102975_bib21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/JVI.79.2.1113-1124.2005","article-title":"Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium","volume":"79","author":"Zhang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102975_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000155","article-title":"CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium","volume":"7","author":"Zhang","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omtn.2026.102975_bib23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.coviro.2012.02.001","article-title":"Pathogenesis of acute respiratory illness caused by human parainfluenza viruses","volume":"2","author":"Schomacker","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.omtn.2026.102975_bib24","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1164\/rccm.201206-1056OC","article-title":"Assessment of F\/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy","volume":"186","author":"Griesenbach","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtn.2026.102975_bib25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/79463","article-title":"Efficient gene transfer to airway epithelium using recombinant Sendai virus","volume":"18","author":"Yonemitsu","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102975_bib26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/sj.gt.3302991","article-title":"Sendai virus-mediated CFTR gene transfer to the airway epithelium","volume":"14","author":"Ferrari","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2026.102975_bib27","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1164\/rccm.202402-0389CI","article-title":"Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial","volume":"210","author":"Davies","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtn.2026.102975_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0992-21","article-title":"Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis","volume":"2","author":"Johnson","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2026.102975_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ng0295-126","article-title":"Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect","volume":"9","author":"Goldman","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2026.102975_bib30","doi-asserted-by":"crossref","first-page":"L1123","DOI":"10.1152\/ajplung.00049.2005","article-title":"Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR","volume":"289","author":"Farmen","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.omtn.2026.102975_bib31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1165\/rcmb.2008-0018OC","article-title":"Functional properties of mixed cystic fibrosis and normal bronchial epithelial cell cultures","volume":"40","author":"Dannhoffer","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.omtn.2026.102975_bib32","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1073\/pnas.1604905113","article-title":"Relationships among CFTR expression, HCO3- secretion, and host defense may inform gene- and cell-based cystic fibrosis therapies","volume":"113","author":"Shah","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102975_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: from molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2026.102975_bib34","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1038\/s41467-023-43904-w","article-title":"Shuttle peptide delivers base editor RNPs to rhesus monkey airway epithelial cells in vivo","volume":"14","author":"Kulhankova","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102975_bib35","doi-asserted-by":"crossref","first-page":"11911","DOI":"10.1093\/nar\/gkae819","article-title":"Amphiphilic shuttle peptide delivers base editor ribonucleoprotein to correct the CFTR R553X mutation in well-differentiated airway epithelial cells","volume":"52","author":"Kulhankova","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102975_bib36","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1164\/rccm.202008-3198OC","article-title":"Secretory Cells Dominate Airway CFTR Expression and Function in Human Airway Superficial Epithelia","volume":"203","author":"Okuda","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.omtn.2026.102975_bib37","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.gt.3302994","article-title":"Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice","volume":"14","author":"Ostrowski","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2026.102975_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3181\/00379727-126-32386","article-title":"Viruses recovered from laboratory dogs with respiratory disease","volume":"126","author":"Binn","year":"1967","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.omtn.2026.102975_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/oxfordjournals.aje.a121307","article-title":"Studies of canine respiratory viruses. I. Experimental infection of dogs with an SV5-like canine parainfluenza agent","volume":"94","author":"Rosenberg","year":"1971","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.omtn.2026.102975_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/vr.98.15.301","article-title":"Isolation of parainfluenza virus SV5 from dogs with respiratory disease","volume":"98","author":"Cornwell","year":"1976","journal-title":"Vet. Rec."},{"key":"10.1016\/j.omtn.2026.102975_bib41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/vr.102.14.293","article-title":"A study of dogs with kennel cough","volume":"102","author":"McCandlish","year":"1978","journal-title":"Vet. Rec."},{"key":"10.1016\/j.omtn.2026.102975_bib42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1292\/jvms1939.50.851","article-title":"Kennel cough complex: confirmation and analysis of the outbreak in Japan. Nihon juigaku zasshi","volume":"50","author":"Azetaka","year":"1988","journal-title":"Jpn. J. Vet. Sci."},{"key":"10.1016\/j.omtn.2026.102975_bib43","article-title":"Evaluating a parainfluenza virus 5-based vaccine in a host with pre-existing immunity against parainfluenza virus 5","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2026.102975_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw0896","article-title":"Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial","volume":"11","author":"Spearman","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.102975_bib45","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1128\/JVI.73.12.9928-9933.1999","article-title":"The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation","volume":"73","author":"Didcock","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102975_bib46","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1128\/jvi.76.5.2159-2167.2002","article-title":"Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha\/beta and gamma interferons","volume":"76","author":"Andrejeva","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2026.102975_bib47","doi-asserted-by":"crossref","first-page":"17264","DOI":"10.1073\/pnas.0407639101","article-title":"The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter","volume":"101","author":"Andrejeva","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102975_bib48","series-title":"Epithelial Cell Culture Protocols","first-page":"115","article-title":"An in vitro model of differentiated human airway epithelia. Methods for establishing primary cultures","author":"Karp","year":"2002"},{"key":"10.1016\/j.omtn.2026.102975_bib49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41551-024-01233-3","article-title":"Systematic optimization of prime editing for the efficient functional correction of CFTR F508del in human airway epithelial cells","volume":"9","author":"Sousa","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.omtn.2026.102975_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.756049","article-title":"Inter-individual Variation in Receptor Expression Influences MERS-CoV Infection and Immune Responses in Airway Epithelia","volume":"9","author":"Li","year":"2022","journal-title":"Front. Public Health"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:08:47Z","timestamp":1788880127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126001460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2162253126001460"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102975","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CFTR gene delivery to human airway epithelia using parainfluenza virus 5 amplifying virus-like particles","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102975"}}